Projects overview

Sort by


Toggle all information

RESTORE VISION | Novel advanced and repurposed therapeutics for vision restoration in a group of severe rare ocular surface diseases: from validation to first clinical investigations

01-05-2023

-

30-04-2027

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.3 Non-Communicable and Rare Diseases
HORIZON-HLTH-2022-DISEASE-06-two-stage
HORIZON-HLTH-2022-DISEASE-06-04-two-stage Development of new effective therapies for rare diseases

TheRaCil | Therapies for Renal Ciliopathies

01-07-2023

-

30-06-2027

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.3 Non-Communicable and Rare Diseases
HORIZON-HLTH-2022-DISEASE-06-two-stage
HORIZON-HLTH-2022-DISEASE-06-04-two-stage Development of new effective therapies for rare diseases

SIMPATHIC | Accelerating drug repurposing for rare neurological, neurometabolic and neuromuscular disorders by exploiting SIMilarities in clinical and molecular PATHology

01-07-2023

-

30-06-2028

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.3 Non-Communicable and Rare Diseases
HORIZON-HLTH-2022-DISEASE-06-two-stage
HORIZON-HLTH-2022-DISEASE-06-04-two-stage Development of new effective therapies for rare diseases

ERAMET | Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines 

01-01-2024

-

31-12-2027

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.3 Non-Communicable and Rare Diseases
HORIZON-HLTH-2023-IND-06
HORIZON-HLTH-2023-IND-06-04 Modelling and simulation to address regulatory needs in the development of orphan and paediatric medicines

EPIC | Enhancing palliative care in ICU

01-01-2024

-

31-12-2028

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.3 Non-Communicable and Rare Diseases
HORIZON-HLTH-2023-DISEASE-03
HORIZON-HLTH-2023-DISEASE-03-01 Novel approaches for palliative and end-of-life care for non-cancer patients

ARISE-NUTRINT | Reducing nutrition-related noncommunicable diseases in adolescence and youth: interventions and policies to boost nutrition fluency and diet quality in Africa

01-01-2023

-

31-12-2026

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.3 Non-Communicable and Rare Diseases
HORIZON-HLTH-2022-DISEASE-07
HORIZON-HLTH-2022-DISEASE-07-03 Non-communicable diseases risk reduction in adolescence and youth (Global Alliance for Chronic Diseases - GACD)

FRESHAIR4LIFE | Implementation research on the tailored, multidisciplinary NCD prevention package FRESHAIR4LIFE: Targeting tobacco and air pollution exposure in mid- to late adolescents in disadvantaged populations

01-01-2023

-

31-12-2026

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.3 Non-Communicable and Rare Diseases
HORIZON-HLTH-2022-DISEASE-07
HORIZON-HLTH-2022-DISEASE-07-03 Non-communicable diseases risk reduction in adolescence and youth (Global Alliance for Chronic Diseases - GACD)

RELEVIUM | Improving quality of life of advanced pancreatic cancer patients through an AI-guided multimodal intervention, combining pain and cachexia management, nutrition, and physical activity

01-09-2022

-

31-08-2026

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.3 Non-Communicable and Rare Diseases
HORIZON-HLTH-2021-DISEASE-04
HORIZON-HLTH-2021-DISEASE-04-01 Improved supportive, palliative, survivorship and end-of-life care of cancer patients

PREFERABLE-II | PREFERABLE-II - Personalised Exercise-Oncology for improvement of supportive care: a super umbrella trial to demonstrate the (cost)effectiveness of live-remote exercise in cancer survivors

01-11-2022

-

31-10-2027

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.3 Non-Communicable and Rare Diseases
HORIZON-HLTH-2021-DISEASE-04
HORIZON-HLTH-2021-DISEASE-04-01 Improved supportive, palliative, survivorship and end-of-life care of cancer patients

EU NAVIGATE | Implementation and evaluation of a Navigation Intervention for People with Cancer in Old Age and their Family Caregivers: an international pragmatic randomized controlled trial

01-09-2022

-

31-08-2027

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.3 Non-Communicable and Rare Diseases
HORIZON-HLTH-2021-DISEASE-04
HORIZON-HLTH-2021-DISEASE-04-01 Improved supportive, palliative, survivorship and end-of-life care of cancer patients

HORUS | Health Outcomes from Raised Urban Settings

01-12-2023

-

30-11-2026

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.3 Non-Communicable and Rare Diseases
HORIZON-HLTH-2023-DISEASE-03
HORIZON-HLTH-2023-DISEASE-03-03 Interventions in city environments to reduce risk of non-communicable disease (Global Alliance for Chronic Diseases - GACD)

INVENTS | Innovative designs, extrapolation, simulation methods and evidence-tools for rare diseases addressing regulatory needs 

01-01-2024

-

31-12-2028

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.3 Non-Communicable and Rare Diseases
HORIZON-HLTH-2023-IND-06
HORIZON-HLTH-2023-IND-06-04 Modelling and simulation to address regulatory needs in the development of orphan and paediatric medicines
Powered by Chris Decubber BV